Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Abiomed Inc (ABMD) Common Stock US$0.01 (CDI)

Sell:$176.55 Buy:$176.68 Change: $2.15 (1.20%)
NASDAQ:0.40%
Market closed |  Prices as at close on 17 October 2019 | Switch to live prices |
Sell:$176.55
Buy:$176.68
Change: $2.15 (1.20%)
Market closed |  Prices as at close on 17 October 2019 | Switch to live prices |
Sell:$176.55
Buy:$176.68
Change: $2.15 (1.20%)
Market closed |  Prices as at close on 17 October 2019 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

ABIOMED, Inc. is a provider of temporary percutaneous mechanical circulatory support devices. The Company offers care to heart failure patients. The Company operates in the segment of the research, development and sale of medical devices to assist or replace the pumping function of the failing heart. The Company develops, manufactures and markets products that are designed to enable the heart to rest, heal and recover by improving blood flow to the coronary arteries and end-organs and/or temporarily performing the pumping function of the heart. The Company's product portfolio includes the Impella 2.5, Impella CP, Impella RP, Impella LD, Impella 5.0 and AB5000. The Company's products are used in the cardiac catheterization lab (cath lab), by interventional cardiologists, the electrophysiology lab, the hybrid lab and in the heart surgery suite by heart surgeons.

Contact details

Address:
22 CHERRY HILL DR
DANVERS
01923-2575
United States
Telephone:
+1 (978) 7775410
Website:
www.abiomed.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
ABMD
ISIN:
US0036541003
Market cap:
$8.07 billion
Shares in issue:
45.38 million
Sector:
Health Care Equipment
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Michael Minogue
    Chairman of the Board, President, Chief Executive Officer
  • Todd Trapp
    Chief Financial Officer, Vice President
  • David Weber
    Chief Operating Officer
  • Ian McLeod
    Vice President, Corporate Controller
  • Michael Howley
    Vice President, General Manager - Global Sales and Marketing
  • Andrew Greenfield
    Vice President, Chief Commercial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.